Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215741 · ClinicalTrials.gov registry record
Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds
A clinical trial of Chronic Wounds and Diabetic Ulcers, sponsored by StimLabs.
- Active
- Registry status
- 50
- Enrollment target
- 3
- Study locations
NCT07215741: Active study of Chronic Wounds and Diabetic Ulcers, sponsored by StimLabs.
NCT07215741 is a study of Chronic Wounds and Diabetic Ulcers that is active but no longer recruiting, run by StimLabs. The registered enrollment target is 50 participants, below the 173-participant average among 4 other Chronic Wounds trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215741, a study of Chronic Wounds and Diabetic Ulcers, is active but no longer recruiting, sponsored by StimLabs.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-world data provides a broad range of experiences related to patient healthcare and treatment.
Primary Outcome
Determine the percent (%) of target ulcers achieving complete wound closure at 12 weeks through the observational period. Target ulcers were defined as all eligible ulcers treated during the observational period. Multiple target ulcers from a single participant were permitted and analyzed individually.
Conditions Studied
Study Locations (3)
Texas
- Premier Foot & Ankle - Denison
- Premier Foot & Ankle - Frisco
Oklahoma
- Cypress Wound Care - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2025-12 |
What the registry record for NCT07215741 still lists
NCT07215741 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 173-participant average among 4 other Chronic Wounds trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Chronic Wounds appearing as the primary indexed condition, and to 0 interventions.
NCT07215741 reports a single indexed study location in Texas, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07215741 about?
NCT07215741 is a clinical study titled "Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds". This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-...
What is the current status of trial NCT07215741?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2025-09-01. Estimated completion is 2025-12.
What conditions does trial NCT07215741 study?
This clinical trial studies the following conditions: Chronic Wounds, Diabetic Ulcers.
Who is sponsoring clinical trial NCT07215741?
This trial is sponsored by StimLabs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215741 being conducted?
This trial has 3 study locations across Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Wounds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI